Funders › CA › Epidermolysis Bullosa Medical Research Foundation › 2025
Grants paid by Epidermolysis Bullosa Medical Research Foundation, tax year 2025
EIN 94-3130081 · Los Angeles, CA · Form 990, Schedule I
In tax year 2025, Epidermolysis Bullosa Medical Research Foundation (EIN 94-3130081) reported 7 grants paid totaling $680,695. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2025
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Stanford University Redwood City, CA | A | $266,950 | paid | RESEARCH | 202621959349300902 |
| 2025 | Eliksa Therapeutics Inc Doylestown, PA | U | $150,000 | paid | RESEARCH | 202621959349300902 |
| 2025 | Nova Anchora LLC New York, NY | A | $125,000 | paid | RESEARCH | 202621959349300902 |
| 2025 | The Children's Hospital of Philadelphia Philadelphia, PA | A | $86,956 | paid | RESEARCH | 202621959349300902 |
| 2025 | Northwestern University Evanston, IL | A | $32,460 | paid | RESEARCH | 202621959349300902 |
| 2025 | Phoenix Children's Hospital Phoenix, AZ | A | $12,500 | paid | RESEARCH | 202621959349300902 |
| 2025 | Uc San Diego Foundation(spf Account) La Jolla, CA | A | $6,829 | paid | RESEARCH | 202621959349300902 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.